Patrick D Yeramian - Net Worth and Insider Trading
Patrick D Yeramian Net Worth
The estimated net worth of Patrick D Yeramian is at least $2 Million dollars as of 2025-07-14. Patrick D Yeramian is the Chief Medical Officer of Amylyx Pharmaceuticals Inc and owns about 205,605 shares of Amylyx Pharmaceuticals Inc (AMLX) stock worth over $2 Million. Details can be seen in Patrick D Yeramian's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Patrick D Yeramian has not made any transactions after 2024-01-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Patrick D Yeramian
Patrick D Yeramian Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Patrick D Yeramian owns 2 companies in total, including BioVie Inc (BIVI) , and Amylyx Pharmaceuticals Inc (AMLX) .
Click here to see the complete history of Patrick D Yeramian’s form 4 insider trades.
Insider Ownership Summary of Patrick D Yeramian
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| BIVI | BioVie Inc | 2018-11-01 | Chief Medical Officer |
| AMLX | Amylyx Pharmaceuticals Inc | 2024-01-09 | Chief Medical Officer |
Patrick D Yeramian Latest Holdings Summary
Patrick D Yeramian currently owns a total of 1 stock. Patrick D Yeramian owns 205,605 shares of Amylyx Pharmaceuticals Inc (AMLX) as of January 9, 2024, with a value of $2 Million.
Latest Holdings of Patrick D Yeramian
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals Inc | 2024-01-09 | 205,605 | 8.16 | 1,676,709 |
Holding Weightings of Patrick D Yeramian
Patrick D Yeramian Form 4 Trading Tracker
According to the SEC Form 4 filings, Patrick D Yeramian has made a total of 6 transactions in Amylyx Pharmaceuticals Inc (AMLX) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Amylyx Pharmaceuticals Inc is the sale of 2,812 shares on January 9, 2024, which brought Patrick D Yeramian around $45,920.
Insider Trading History of Patrick D Yeramian
- 1
Patrick D Yeramian Trading Performance
Patrick D Yeramian Ownership Network
Ownership Network List of Patrick D Yeramian
Ownership Network Relation of Patrick D Yeramian
Patrick D Yeramian Owned Company Details
What does BioVie Inc do?
Who are the key executives at BioVie Inc?
Patrick D Yeramian is the Chief Medical Officer of BioVie Inc. Other key executives at BioVie Inc include Chief Financial Officer Joanne Wendy Kim , other: Chief Medical Officer Joseph M Palumbo , and EVP Liver Cirrhosis Programs Jonathan M Adams .
BioVie Inc (BIVI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of BioVie Inc (BIVI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioVie Inc (BIVI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
BioVie Inc (BIVI)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioVie Inc Insider Transactions
Patrick D Yeramian Mailing Address
Above is the net worth, insider trading, and ownership report for Patrick D Yeramian. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Patrick D Yeramian's mailing address is: Boca Raton Fl 33486.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
